Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 20.19M P/E - EPS this Y 69.90% Ern Qtrly Grth -
Income -38.76M Forward P/E 6.87 EPS next Y 148.00% 50D Avg Chg -7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -44.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -82.00%
Recommedations 2.50 Quick Ratio 0.04 Shares Outstanding 24.46M 52W Low Chg 27.00%
Insider Own 13.78% ROA -65.27% Shares Float 18.37M Beta 0.44
Inst Own 29.91% ROE - Shares Shorted/Prior 493.55K/898.08K Price 0.82
Gross Margin - Profit Margin - Avg. Volume 169,687 Target Price 1.50
Oper. Margin - Earnings Date Mar 25 Volume 188,362 Change -2.83%
About Acer Therapeutics Inc.

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company's pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-801 for the treatment of induced Vasomotor Symptoms, post-traumatic stress disorder, and prostate cancer; and OLPRUVA, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. It has a license agreement with Sanofi to acquire worldwide rights to Osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist; an option agreement with Relief for the development, regulatory approval, and commercialization of OLPRUVA; and an agreement with Emory University to acquire the worldwide intellectual property rights to a family of patents and patent applications related to the use of neurokinin receptor antagonists in managing conditioned fear and treating anxiety disorders, including post-traumatic stress disorder. The company was incorporated in 1991 and is headquartered in Newton, Massachusetts. As of November 17, 2023, Acer Therapeutics Inc. operates as a subsidiary of Zevra Therapeutics, Inc.

ACER Chatroom

User Image Mibo48 Posted - 5 days ago

$ZVRA How are the $ACER CVR's going? Is there any probability of some milestones being paid out in the next few months?

User Image enezyfm Posted - 10/29/24

$ACER CVRs ...%........!.........? When Acer theraputics CVRs.

User Image Ajk222 Posted - 10/24/24

$ACER @intowits please define expire date for ACER CVR'S... Also is it based upon a 75M or 25M potential....?? Is it still possible, however unlikely that ZVRA could receive a voucher ?? http://stocktwits.com/flybyme/message/552239316

User Image RookieTrader500 Posted - 4 weeks ago

$ACER oooof

User Image Ajk222 Posted - 3 months ago

$ACER Clear as mud... as to what RLFTF board is doing it appears.... but at least other businesses like SWK & ZVRA are doing something... see comments from an old RLF investor like myself too on NRXP ... https://www.crweworld.com/article/news-provided-by-accesswire/3447579/relief-therapeutics-secures-up-to-11-million-from-royalty-sales

User Image CooperHandy Posted - 3 months ago

$ACER $ZVRA Nothing… This is for Arimoclomol and has nothing to do with ACER acquisition 😉🤝

User Image GreenSharken Posted - 3 months ago

$ZVRA When and how much will $ACER CRV holders receive this first tranche?

User Image Kkhaledd2 Posted - 4 months ago

$ACER when they give us our money ?

User Image enezyfm Posted - 06/24/24

$ACER

User Image enezyfm Posted - 05/29/24

$ACER One day..... Inshallah. Be patient.... Regards

User Image enezyfm Posted - 6 months ago

$ACER What about our rights. ACER.CVR .........

User Image flybyme Posted - 04/29/24

$ACER

User Image enezyfm Posted - 04/28/24

$ACER Gentlemen let's acer management's explaining contingent value ✅️ Rights (CVRs). Waiting for answers Regards

User Image _nic Posted - 7 months ago

@Joesh82 hcw is worth shit $NRXP $RLFTF $ACER

User Image enezyfm Posted - 7 months ago

$ACER What about ACER VCRs!!!!

User Image enezyfm Posted - 7 months ago

$ACER

User Image enezyfm Posted - 7 months ago

$ACER

User Image enezyfm Posted - 03/27/24

$ACER

User Image enezyfm Posted - 03/26/24

$ACER

User Image enezyfm Posted - 03/23/24

$ACER Dear ACER shareholders Please now our concern and focus on ACER CVRs only. Everybody must fighting and fighting till we receive our acer CVRs. Now....its a message to acer management and zvra management...if you forget or hidden our acer theraputics cvrs ..... I can't write what will happen. I challenge It's our money It's our money It's our money We didn't cheating anybody... But...but...but you cheating us...you will see the result soon. Enough.

User Image enezyfm Posted - 7 months ago

$ACER 👋

User Image saleh1010 Posted - 8 months ago

$ACER merger is complete what’s next where is our money

User Image enezyfm Posted - 8 months ago

$ACER acer stockholders...we want latest news.

User Image salems Posted - 8 months ago

$ACER $ZVRA Where is the rest of the money we promised to get from the acquisition?

User Image enezyfm Posted - 02/29/24

$ACER Any updating Pleaseeeeee

User Image enezyfm Posted - 02/29/24

$ACER anyabdating February 2024 gone...

User Image flybyme Posted - 9 months ago

$ACER Zevar shares are doing ok , a steady climb.

User Image Jon752 Posted - 9 months ago

$acer $ZVRA Schwab and Etrade are reporting the sale two different ways on the 1099. Etrade is showing it as a sale of Acer stock and a purchase of Zevra (which aligns with the prospectus). Schwab does not show the transaction on the 1099. I don't really care which way it is reported, I just don't want to give the IRS a reason to question my returns.

User Image enezyfm Posted - 9 months ago

$ACER Any updates.

User Image Jon752 Posted - 9 months ago

$ACER $ZVRA Until I received my 1099, I didn't realize that the buyout of acer by zvra was a taxable event.

Analyst Ratings
HC Wainwright & Co. Neutral Sep 5, 23
Roth Capital Neutral Sep 1, 23
Roth MKM Neutral Sep 1, 23
HC Wainwright & Co. Buy Mar 28, 23
EF Hutton Buy Mar 20, 23
EF Hutton Buy Feb 2, 22
Needham Hold Jun 25, 19
Wedbush Outperform May 23, 19
Needham Buy Dec 20, 18